Clinical Trial Update: Effect of Montelukast on Inflammatory Markers and Cardiac Injury in Patients With Acute Myocardial Infarction [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update examining whether montelukast affects inflammatory markers and cardiac injury in patients with acute myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Montelukast (Montelukast)

Snippet

Sponsor: October 6 University | Conditions: Acute Myocardial Infarction (AMI) | Phase 2 | Status: NOT_YET_RECRUITING